GE Healthcare Q2 Prelim Likely to Ease Overhang, RBC Says

MT Newswires Live07-24 23:58

GE Healthcare Technologies' (GEHC) preliminary Q2 report should ease investor worries over cost inflation and other issues, RBC Capital Markets said in a Thursday note.

The firm pre-released Q2 results with organic revenue above consensus and a material EPS upside surprise, the report said. GE also said CFO James Saccaro will step down from his role.

The note said it was a "positive" event for the stock amid cautious investor sentiment heading into Q2 over cost inflation, tariff headwinds, and hospital capital spending uncertainty.

"We believe the constructive tone (strong orders, healthy end market demand)...paired with 2026 guide reaffirmation should help alleviate some near-term overhang and the CFO transition," the report said.

RBC maintained its outperform rating and a $80 price target.

Price: 61.35, Change: -0.64, Percent Change: -1.03

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment